ATGC Inc. is dedicated to the development of novel transgenic rabbits as discovery platforms and bioreactors for therapeutic biologics.
Monoclonal Antibody Development
Rabbit strains and transgenic lines for antibody development
Antigen Design and Peptide Synthesis
Peptides for animal immunization at >95% purity

ATGC is “A Translational Genomics Company”. We’re dedicated to advancing the development of novel transgenic rabbits as innovative platforms for drug discovery and biomanufacturing.
Our mission is to discover the best-in-class therapeutics through cutting-edge genomic products. ATGC also strives to serve the biomedical community by offering specialized products and services built on our proprietary platforms.